Extensive research has been conducted on the isolation and study of bioactive compounds derived from marine sources. Several natural products have demonstrated potential as inducers of apoptosis and are currently under investigation in clinical trials. These marine-derived compounds selectively interact with extrinsic and intrinsic apoptotic pathways using a variety of molecular mechanisms, resulting in cell shrinkage, chromatin condensation, cytoplasmic blebs, apoptotic bodies, and phagocytosis by adjacent parenchymal cells, neoplastic cells, or macrophages. Numerous marine-derived compounds are currently undergoing rigorous examination for their potential application in cancer therapy. This review examines a total of 21 marine-derived compounds, along with their synthetic derivatives, sourced from marine organisms such as sponges, corals, tunicates, mollusks, ascidians, algae, cyanobacteria, fungi, and actinobacteria. These compounds are currently undergoing preclinical and clinical trials to evaluate their potential as apoptosis inducers for the treatment of different types of cancer. This review further examined the compound’s properties and mode of action, preclinical investigations, clinical trial studies on single or combination therapy, and the prospective development of marine-derived anticancer therapies.
Marine sediments host diverse actinomycetes that serve as a source of new natural products to combat infectious diseases and cancer. Here, we report the biodiversity, bioactivities against ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) and ovarian cancer, and metabolites variation among culturable actinomycetes isolated from the marine sediments of Visayan Sea, Philippines. We identified 15 Streptomyces species based on a 16S rRNA gene sequence analysis. The crude extracts of 10 Streptomyces species have inhibited the growth of ESKAPE pathogens with minimum inhibitory concentration (MIC) values ranging from 0.312 mg/mL to 20 mg/mL depending on the strain and pathogens targeted. Additionally, ten crude extracts have antiproliferative activity against A2780 human ovarian carcinoma at 2 mg/mL. To highlight, we observed that four phylogenetically identical Streptomyces albogriseolus strains demonstrated variation in antibiotic and anticancer activities. These strains harbored type I and II polyketide synthase (PKS) and non-ribosomal synthetase (NRPS) genes in their genomes, implying that their bioactivity is independent of the polymerase chain reaction (PCR)-detected bio-synthetic gene clusters (BGCs) in this study. Metabolite profiling revealed that the taxonomically identical strains produced core and strain-specific metabolites. Thus, the chemical diversity among these strains influences the variation observed in their biological activities. This study expanded our knowledge on the potential of marine-derived Streptomyces residing from the unexplored regions of the Visayan Sea as a source of small molecules against ESKAPE pathogens and cancer. It also highlights that Streptomyces species strains produce unique strain-specific secondary metabolites; thus, offering new chemical space for natural product discovery.
Ginger (Zingiber officinale) is a widely recognized functional food, known for its anti-inflammatory, antioxidant, and digestive health benefits largely attributed to gingerol-related compounds. While traditional extraction-based methods have been used to characterize these metabolites, they often compromise the spatial context within tissues. This study represents the first application of matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) with ion mobility spectrometry (IMS) to map the detailed spatial distribution of key ginger metabolites (6-, 8-, and 10-gingerols and shogaols) in a complex matrix of an intact rhizome tissue. Rhizomes from five ginger accessions collected in Negros Occidental, Philippines, were cryosectioned at 20 μm, coated with 2,5-dihydroxybenzoic acid (DHB) matrix, and analyzed using MALDI MSI at 100 µm spatial resolution across an m/z range of 50–1200. The MALDI MSI revealed that 6-, 8-, and 10-gingerols were predominantly localized in the stele and cortex regions, while shogaols exhibited broader distribution, including the epidermis. Principal component analysis (PCA) on UPLC-ESI-QTOF-MS data of methanolic rhizome extracts revealed clustering patterns among the five ginger accessions. These findings provide a spatially resolved metabolomic profile of gingerols and shogaols, offering novel insights into the anatomical localization of bioactive compounds. This integrative approach establishes a foundation for future studies on ginger physiology, breeding, and quality control of ginger-derived natural products.
About Me
Aspiring Scientist from the Center for Chemical Biology and Biotechnology, University of San Agustin, Iloilo City, Philippines
Aspiring Scientist from the Center for Chemical Biology and Biotechnology, University of San Agustin, Iloilo City, Philippines